Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 442Rectal Neoplasms 209Colonic Neoplasms 202Pancreatic Neoplasms 133Stomach Neoplasms 117Neoplasm Metastasis 97Neoplasms 64Esophageal Neoplasms 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Lymphoma 49Leukemia 41Carcinoma, Hepatocellular 41Adenocarcinoma Of Esophagus 37Burkitt Lymphoma 33Adenocarcinoma 29Cholangiocarcinoma 27Biliary Tract Neoplasms 23Carcinoma, Non-Small-Cell Lung 21Gastrointestinal Neoplasms 20Gallbladder Neoplasms 20Lymphoma, Non-Hodgkin 19Esophageal Squamous Cell Carcinoma 15Osteosarcoma 14Liver Neoplasms 14Bile Duct Neoplasms 14Unspecified Adult Solid Tumor, Protocol Specific 13Lymphoma, Large B-Cell, Diffuse 13Leukemia, Biphenotypic, Acute 13Ovarian Neoplasms 12Leukemia, Myeloid, Acute 12

Interventions

Oxaliplatin 1Leucovorin 1Folic Acid 1Fluorouracil 1Drug Therapy 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX × Leucovorin × Clear all
NCT05378919 2022-05-18

RECTUM2015

Lithuanian University of Health Sciences

Phase 2 Recruiting
250 enrolled
Gastrointestinal

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Data powered by HemOnc (CC BY 4.0) Colophon âš¡